Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).
https://gardp.org/this-is-big/
https://gardp.org/this-is-big/
🚨 Final Day to Submit!
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
November 14, 2025 at 10:43 AM
🚨 Final Day to Submit!
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
🎤 GARDP is partnering with Swissnex India for the AMR Poetry Slam & Open Mic.
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
November 14, 2025 at 7:04 AM
🎤 GARDP is partnering with Swissnex India for the AMR Poetry Slam & Open Mic.
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by Charité - Universitätsmedizin Berlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE)
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
November 12, 2025 at 9:14 AM
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by Charité - Universitätsmedizin Berlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE)
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
📢 10 days left to submit abstracts for #ACC2026!
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
November 5, 2025 at 7:06 AM
We’re excited to share that 1,052 people joined our latest #REVIVE webinar — our biggest yet!🎉
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
November 2, 2025 at 7:00 AM
We’re excited to share that 1,052 people joined our latest #REVIVE webinar — our biggest yet!🎉
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D.
Missed it? Watch our AI-focused session here 👇
🔗 bit.ly/48ZxRDo
Our DER team has been out at key scientific forums this year, presenting work in early antibiotic discovery.
Take a look at their posters👇
Take a look at their posters👇
October 31, 2025 at 8:36 AM
Our DER team has been out at key scientific forums this year, presenting work in early antibiotic discovery.
Take a look at their posters👇
Take a look at their posters👇
⏰ Don’t miss your chance to present at #ACC2026!
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
October 28, 2025 at 12:12 PM
⏰ Don’t miss your chance to present at #ACC2026!
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully.
Submit now 🔗 acc-conference.com#posters
🔴 Live TODAY!
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
October 28, 2025 at 6:00 AM
🔴 Live TODAY!
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.
🗓️17:00–18:30 CET
👉 Join here: go.bsky.app/redirect?u=h...
#AMR #Antibiotics #AI #REVIVE
📢 Last chance to register!
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
October 27, 2025 at 6:58 AM
📢 Last chance to register!
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
How can #AI help detect and predict antimicrobial resistance?
Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions).
🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online
👉 Register: bit.ly/4hqdyky
🗓️ 2 days to go!
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
October 26, 2025 at 3:34 AM
🗓️ 2 days to go!
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
Can #AI reshape how we detect and manage antimicrobial resistance?
Find out in our #REVIVE webinar on 28 Oct, 17:00 CET.
👉 Register: revive.gardp.org/webinars/
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
October 23, 2025 at 6:06 AM
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
📢 Exciting news!
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
October 20, 2025 at 8:22 AM
📢 Exciting news!
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal.
This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
Thank you for attending #BioJapan 2025
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
October 16, 2025 at 8:12 AM
Thank you for attending #BioJapan 2025
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨
⏳ One month to go!
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
October 16, 2025 at 6:11 AM
⏳ One month to go!
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR.
Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more.
Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
🌍 At #WHS2025, GARDP’s Peter Beyer highlighted the impact of tech transfers in a #GSK session.
"Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."
"Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."
October 14, 2025 at 6:32 AM
Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide.
👉 Submit your nomination: penta-id.org/bfa
👉 Submit your nomination: penta-id.org/bfa
October 13, 2025 at 6:52 AM
Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide.
👉 Submit your nomination: penta-id.org/bfa
👉 Submit your nomination: penta-id.org/bfa
We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
October 13, 2025 at 4:38 AM
We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
A big Thank You to our 2026 REVIVE programme Advisory Group members.
When asked what GARDP expects from Japan in the fight against #AMR at the Nikkei-FT Infectious Disease Conference session, Rahul Dwivedi of #GARDP said:
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
October 13, 2025 at 3:02 AM
📝 Call for abstracts is open for #ACC2026!
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
October 8, 2025 at 6:15 AM
📝 Call for abstracts is open for #ACC2026!
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Researchers are invited to share their work on #AMR for short talks or poster presentations.
💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.
⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
Finally, #BioJapan2025 starts tomorrow!
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
October 7, 2025 at 7:35 AM
Finally, #BioJapan2025 starts tomorrow!
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
October 7, 2025 at 7:33 AM
🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."
– Jennifer Cohn, GARDP
– Jennifer Cohn, GARDP
October 5, 2025 at 2:28 AM
"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."
– Jennifer Cohn, GARDP
– Jennifer Cohn, GARDP
This week, GARDP joined the PDP Funders Group in Thailand.
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
October 4, 2025 at 10:13 AM
This week, GARDP joined the PDP Funders Group in Thailand.
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
October 4, 2025 at 8:58 AM
The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
During our Tokyo visit, we met Ms Akiko Honda, Member of the House of Councillors, to discuss Japan’s role in global health🌍
💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.
💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.
October 4, 2025 at 8:57 AM
During our Tokyo visit, we met Ms Akiko Honda, Member of the House of Councillors, to discuss Japan’s role in global health🌍
💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.
💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.